GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embla Medical hf (OCSE:EMBLA) » Definitions » Debt-to-Revenue

Embla Medical hf (OCSE:EMBLA) Debt-to-Revenue : 0.70 (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Embla Medical hf Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Embla Medical hf's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was kr577 Mil. Embla Medical hf's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was kr3,262 Mil. Embla Medical hf's annualized Revenue for the quarter that ended in Mar. 2024 was kr5,484 Mil. Embla Medical hf's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 was 0.70.


Embla Medical hf Debt-to-Revenue Historical Data

The historical data trend for Embla Medical hf's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embla Medical hf Debt-to-Revenue Chart

Embla Medical hf Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.53 0.77 0.62 0.67 0.60

Embla Medical hf Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.68 0.60 0.59 0.56 0.70

Competitive Comparison of Embla Medical hf's Debt-to-Revenue

For the Medical Devices subindustry, Embla Medical hf's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Embla Medical hf's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Embla Medical hf's Debt-to-Revenue falls into.



Embla Medical hf Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Embla Medical hf's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(296.118 + 2900.737) / 5369.986
=0.60

Embla Medical hf's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(577.424 + 3262.384) / 5483.78
=0.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2024) Revenue data.


Embla Medical hf Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Embla Medical hf's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Embla Medical hf (OCSE:EMBLA) Business Description

Traded in Other Exchanges
Address
Grjothals 5, Reykjavik, ISL
Ossur hf is engaged in the design, development, manufacture, and sale of prosthetics and bracing & support products. The company's products improve mobility through technologies in the field of braces, supports, prosthetic limbs, and compression therapy. Its segments are the Bracing & Supports and Prosthetics segment. The bracing & support products are used to support joints and other body parts for therapeutic and preventative purposes. The Prosthetics segment includes artificial limbs and related products for individuals born without limbs. Its geographical segments are the Americas; Europe, the Middle East & Africa (EMEA); and the Americas & Asia-Pacific (APAC), of which the Americas generate nearly half of the company's revenue.

Embla Medical hf (OCSE:EMBLA) Headlines

No Headlines